International Society for Biological and Environmental Repositories

International Society for Biological and Environmental Repositories
Name	International Society for Biological and Environmental Repositories
Abbreviation	ISBER
Formation	1999
Type	Professional society
Headquarters	Vancouver, British Columbia
Region served	International
Leaders	Board of Directors

International Society for Biological and Environmental Repositories is a global professional association focused on biobanking, specimen repositories, and environmental sample curation. The society engages stakeholders from academic institutions such as Harvard University, Stanford University, and University of Cambridge, governmental agencies like National Institutes of Health, Centers for Disease Control and Prevention, and Public Health England, as well as industry partners including Pfizer, Roche, and Novartis. It operates at the intersection of translational research initiatives exemplified by Human Genome Project, 1000 Genomes Project, and All of Us Research Program and contributes to standards used by organizations such as World Health Organization and Organisation for Economic Co-operation and Development.

History

ISBER emerged in the context of late 20th century efforts to organize specimen-based research, tracing influences from initiatives including Human Genome Project, National Cancer Institute, and networks like Biobanking and Biomolecular Resources Research Infrastructure and European Molecular Biology Laboratory. Early meetings featured participants from Cold Spring Harbor Laboratory, Mayo Clinic, Karolinska Institutet, and Johns Hopkins University. The society’s development paralleled policy shifts involving National Research Council reports, guidance from Food and Drug Administration, and collaborations with Wellcome Trust, Bill & Melinda Gates Foundation, and Canadian Institutes of Health Research.

Mission and Objectives

ISBER’s mission aligns with objectives promoted by World Health Organization, UNESCO, and Council of Europe on quality, access, and ethics for biospecimens. It aims to harmonize practices seen in consortia like International Cancer Genome Consortium, European Genome-phenome Archive, and Global Alliance for Genomics and Health by producing guidance compatible with standards from International Organization for Standardization, Clinical and Laboratory Standards Institute, and International Council for Harmonisation. The society emphasizes ethical frameworks influenced by rulings and instruments from European Court of Human Rights, United States Supreme Court, and declarations like the Declaration of Helsinki.

Membership and Governance

Membership encompasses professionals from universities such as University of Oxford, University of Toronto, and Yale University; public agencies including Centers for Medicare & Medicaid Services, Public Health Agency of Canada, and European Centre for Disease Prevention and Control; and corporations like GlaxoSmithKline, AstraZeneca, and Illumina. Governance is conducted via a Board of Directors and committees analogous to governance structures of American Medical Association, Royal Society, and National Academy of Sciences. ISBER’s policies reflect legal frameworks from jurisdictions such as United States, United Kingdom, European Union, and Japan and engage with regulatory bodies including Health Canada and European Medicines Agency.

Standards and Best Practices

The society publishes best practice documents that interface with standards from International Organization for Standardization, Clinical and Laboratory Standards Institute, and Good Clinical Practice. These guidelines inform specimen handling for studies tied to projects like The Cancer Genome Atlas, Horizon 2020, and Biobank Japan and are used by repositories at institutions such as Sanger Institute, Fred Hutchinson Cancer Research Center, and Memorial Sloan Kettering Cancer Center. Ethical and legal considerations reference instruments from Council of Europe, European Convention on Human Rights, and policies from National Institutes of Health and Wellcome Trust.

Conferences and Education

ISBER convenes annual meetings and workshops attracting delegates from organizations such as World Health Organization, European Bioinformatics Institute, Cold Spring Harbor Laboratory, and Broad Institute. Programmes include training aligned with curricula from Johns Hopkins Bloomberg School of Public Health, London School of Hygiene & Tropical Medicine, and Mayo Clinic School of Continuous Professional Development. Special sessions have featured speakers affiliated with Harvard Medical School, Stanford School of Medicine, and Karolinska Institutet, and collaborative events have been held in cities like Vancouver, London, Boston, and Tokyo.

Research and Collaborations

ISBER supports research networks and collaborates with consortia such as Global Alliance for Genomics and Health, International Cancer Genome Consortium, and Biobanking and Biomolecular Resources Research Infrastructure. Partnerships extend to funders and organizations including Wellcome Trust, Bill & Melinda Gates Foundation, National Institutes of Health, and European Commission programs like Horizon Europe. Collaborations have facilitated projects involving repositories at University of California, San Francisco, University of Pennsylvania, and University of Melbourne and interfaces with infrastructure providers like European Genome-phenome Archive and dbGaP.

Category:Biobanking organizations